The global stem cell therapy market is growing at a significant pace due to increasing awareness regarding the therapeutic power of stem cells and the development of infrastructure related to stem cell banking and processing. The market has seen a high demand for allogeneic therapies over the last few years, due to easy production scale-up process, and increasing commercialization of allogeneic therapy products.
Request for Free Sample Copy of this Research Report at: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market/request-sample
Insight by Type
There are two kinds of stem cell therapy, allogeneic and autologous. For both, allogenic segment accounts for the bigger share and is also predicted to grow at the faster pace in the coming years in the global market due to its extensive therapeutic applications, increasing commercialization of allogeneic products, easy production scale-up process, and the rising number of clinical trials related to allogeneic therapies.
Insight by Therapeutic Application
The stem cell therapy market has been sub-segmented by the therapeutic application into gastrointestinal diseases, musculoskeletal disorders, surgeries, cardiovascular diseases, and wound and injuries. Musculoskeletal disorders category contributed the biggest revenue in the market due to the increasing prevalence of musculoskeletal disorders and bone & joint diseases, increasing the availability of stem cell-based products for the treatment of musculoskeletal disorders, and growing patient preference for effective & early, fast treatment strategies.
Insight by Cell Source
The worldwide stem cell therapy market has also been classified by cell source into an adipose tissue-derived mesenchymal stem cell, cord blood cells, and bone marrow-derived mesenchymal stem cells.
The rising awareness related to the therapeutic potential of stem cells, development of infrastructure related to stem cell banking and processing, development of advanced genome-based cell analysis techniques, and growing private-public investment for the development of stem cell therapies are the primary growth drivers for stem cell therapy market. As per the World Health Organization (WHO) globally, more than 50,000 transplants are carried out annually and it is increasing each year.
The growing prevalence of chronic diseases, supporting regulations across developing countries, technological advancement in healthcare, cellular therapies are the major advancements in transforming healthcare and identification of new stem cell lines are also powering the growth of the stem cell therapy market. Diseases like osteoarthritis, multiple sclerosis, heart failure, hearing loss, and cerebral palsy are some of the diseases that could be treated using stem cell therapies. According to the WHO by 2050, it is estimated 900 million people will have disabling hearing loss. Furthermore, 60 percent of childhood hearing loss is due to preventable causes.
However, restrictions of traditional organ transplantation such as dependence on organ donor, the threat of infection, rejection, and immunosuppression threat and increasing pipeline and development of drugs for emerging applications are also boosting the growth of the stem cell therapy market.
The technical limitations related to production scale-up, socio-ethical issues related to the use of stem cell in disease treatment and research and unclear regulatory guidelines for product development & commercialization are the key challenges for the growth for the stem cell therapy market. The socio-ethical issues involved in stem cell research likewise religious briefs and destruction of the human embryo are considered as the hindering factor for the adaptation of stem cell therapy by the patient.
However, a high cost of research, less developed research infrastructure for stem cell therapies and storage of stem cell, difficulty related with the preservation of stem cell, and strict regulations to conduct trials on human are also hindering the growth of the stem cell therapy market.
The main challenges for the new entrants are the subsistence in the capital demanding and highly regulated stem cell therapy market. furthermore, the competition among the players also increases due to less product differentiation.
Browse Full Research Report Description at: https://www.vynzresearch.com/healthcare/single-use-bioreactor-market
Globally, North America is the biggest stem cell therapy market and is witness the fastest growth in the market. Some of the key factors leading to the growth of the North American stem cell therapy market are increasing number of clinical trials to evaluate therapeutic potential of products, rising prevalence of chronic diseases, the growing patient base for target diseases, growing public awareness related to the therapeutic potency of therapy, and increasing public-private funding & research grants for developing safe and effective stem cell therapy products.
Key players in the industry are capitalizing in the development of technologically inventive and advanced products, which is strengthening their position in the stem cell therapy market globally. In March 2017, Osiris Therapeutics launched Prestige Biotechnology, a method for storage of living cells and tissues. In addition, in February 2018, MEDIPOST announced that the FDA has approved its stem cell-based Alzheimer’s disease drug, NEUROSTEM for clinical trials. Osiris Therapeutics, Inc., RTI Surgical, Inc., MEDIPOST Co., Ltd., Nuvasive, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., and Allosource are some of the key players offering stem cell therapy products.
Source: VynZ Research